Low serum amylase in association with metabolic syndrome and diabetes: A community-based study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Nakajima, Kei ^a,d   Nemoto, Tohru ^a   Muneyuki, Toshitaka ^b   Kakei, Masafumi ^b   Fuchigami, Hiroshi ^c   Munakata, Hiromi ^d  

^a JOSAI UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Social Insurance Omiya General Hospital   (Japan)

^d Social Health Insurance OMIYA General Hospital   (Japan)

Author keywords

Diabetes; GFR; Impaired insulin action; Kidney function; Metabolic syndrome; Serum amylase exocrine

Indexed keywords

AMYLASE; GLUCOSE; BIOLOGICAL MARKER;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CONFIDENCE INTERVAL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANCREAS FUNCTION; PERIODIC MEDICAL EXAMINATION; RISK; RISK FACTOR; ANALYSIS OF VARIANCE; BLOOD; DOWN REGULATION; ENZYMOLOGY; GLUCOSE TOLERANCE TEST; JAPAN; KIDNEY; METABOLISM; MIDDLE AGED; PANCREAS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; TIME;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; DOWN-REGULATION; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE TOLERANCE TEST; HUMANS; JAPAN; KIDNEY; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PANCREAS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79955103876     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-34     Document Type: Article

References (28)

1. Yegneswaran B, Pitchumoni CS. When should serum amylase and lipase levels be repeated in a patient with acute pancreatitis?. Cleve Clin J Med 2010, 77:230-231. 10.3949/ccjm.77a.09083, 20360115.
2. Skrha J, Stěpán J. Clinical significance of amylase isoenzyme determination. Acta Univ Carol Med Monogr 1987, 120:1-81.
3. Pieper-Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go?. Gastroenterol Clin North Am 1990, 19:793-810.
4. Kjaergaard JJ, Salling N, Magid E, Ditzel J. Serum amylase during recovery from diabetic ketoacidosis. Diabete Metab 1984, 10:25-30.
5. Junge W, Mályusz M, Ehrens HJ. The role of the kidney in the elimination of pancreatic lipase and amylase from blood. J Clin Chem Clin Biochem 1985, 23:387-392.
6. Collen MJ, Ansher AF, Chapman AB, Mackow RC, Lewis JH. Serum amylase in patients with renal insufficiency and renal failure. Am J Gastroenterol 1990, 85:1377-1380.
7. Sterkel RL, Kirsner JB. The laboratory diagnosis of pancreatic disease. AMA Arch Intern Med 1958, 101:114-129.
8. Domínguez-Muñoz JE, Pieramico O, Büchler M, Malfertheiner P. Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. Digestion 1993, 54:231-236.
9. Maruyama K, Takahashi H, Okuyama K, Yokoyama A, Nakamura Y, Kobayashi Y, Ishii H. Low serum amylase levels in drinking alcoholics. Alcohol Clin Exp Res 2003, 27:16S-21S. 10.1097/01.ALC.0000078827.46112.76, 12960501.
10. Frier BM, Faber OK, Binder C, Elliot HL. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia 1978, 14:301-304. 10.1007/BF01223020, 348540.
11. Dandona P, Freedman DB, Foo Y, Perkins J, Katrak A, Mikhailidis DP, Rosalki SB, Beckett AG. Exocrine pancreatic function in diabetes mellitus. J Clin Pathol 1984, 37:302-306. 10.1136/jcp.37.3.302, 498704, 6699193.
12. Swislocki A, Noth R, Hallstone A, Kyger E, Triadafilopoulos G. Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus. Horm Metab Res 2005, 37:326-330. 10.1055/s-2005-861478, 15971157.
13. Aughsteen AA, Abu-Umair MS, Mahmoud SA. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus. Saudi Med J 2005, 26:73-77.
14. Schneeman BO, Inman MD, Stern JS. Pancreatic enzyme activity in obese and lean Zucker rats: a developmental study. J Nutr 1983, 113:921-925.
15. Trimble ER, Bruzzone R, Belin D. Insulin resistance is accompanied by impairment of amylase-gene expression in the exocrine pancreas of the obese Zucker rat. Biochem J 1986, 237:807-812. 1147060, 2432875.
16. Kanno T, Saito A. The potentiating influences of insulin on pancreozymin-induced hyperpolarization and amylase release in the pancreatic acinar cell. J Physiol 1976, 261:505-521. 1309157, 978585.
17. Farese RV, Larson RE, Sabir MA. Insulin and its secretagogues activate Ca2+-dependent phosphatidylinositol breakdown and amylase secretion in rat pancreas in vitro. Diabetes 1981, 30:396-401. 10.2337/diabetes.30.5.396, 6164587.
18. Williams JA, Goldfine ID. The insulin-pancreatic acinar axis. Diabetes 1985, 34:980-986. 10.2337/diabetes.34.10.980, 2412919.
19. Barreto SG, Carati CJ, Toouli J, Saccone GT. The islet-acinar axis of the pancreas: more than just insulin. Am J Physiol Gastrointest Liver Physiol 2010, 299:G10-22. 10.1152/ajpgi.00077.2010, 20395539.
20. Belfiore F, Lo Vecchio L, Napoli E. Serum enzymes in diabetes mellitus. Clin Chem 1973, 19:447-452.
21. The committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010, 53:450-467. The committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, . Collaborators developing the Japanese equation for estimated GFR Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992. 10.1053/j.ajkd.2008.12.034, 19339088, Collaborators developing the Japanese equation for estimated GFR.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, . American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765, American Heart Association; National Heart, Lung, and Blood Institute.
24. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69. 2797383, 20042775, American Diabetes Association.
25. Eliasson B, Attvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994, 14:1946-1950.
26. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008, 87:801-809.
27. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 2010, 9:18. 10.1186/1475-2840-9-18, 2877657, 20470427.
28. Hayden MR, Patel K, Habibi J, Gupta D, Tekwani SS, Whaley-Connell A, Sowers JR. Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities. J Cardiometab Syndr 2008, 3:234-243. 10.1111/j.1559-4572.2008.00024.x, 2646502, 19040593.